The Increasing Complexity of Clinical Trials and How it Impacts Comparator Supply
Clinical trial designs are becoming increasingly complex, driven by adaptive protocols, precision medicine, expanding global footprints, and accelerating development timelines. As studies evolve, traditional comparator sourcing approaches are being challenged in new ways.
Why Comparator Strategy Starts at Protocol Design
A clinical trial protocol has to take many things into consideration, and the way that the comparator drug is listed is perhaps one of the simpler (or at least shorter) parts of a very detailed and involved document. As a result, the importance of it can be overlooked.
How Innovation in Commercial Medicines Impacts Clinical Supply Chains
How Innovation in
Commercial Medicines
Impacts Clinical Supply
Chains by Midwinter Solutions
Minimizing the frequency and impact of temperature excursions in clinical trial logistics
Ensuring End-to-End Temperature Stability in Clinical Trial Logistics: A Proactive Approach by Midwinter Solutions
A Guide to Documentation for Comparators
Comparator documentation can make or break a sourcing strategy. The right balance ensures compliance and patient safety without adding unnecessary cost or delays.
Falsified products in the Clinical Trial supply chain
Organisations handling medicinal products must have processes to detect and remove unauthorised products from the supply chain. Find out more in our article.
Import/export and Clinical Trial supply
A steady and reliable supply of medicines is critical to a clinical trial’s success.
Effective strategies for mitigating the risk of comparator shortages in a Clinical Trial
Interested in mitigating the risk of comparator shortages? Read our article for effective Clinical Trial strategies.
Considerations for selecting the right comparator drug for your Clinical Trial
Selecting the right comparator drug for your clinical trial; how can your vendor help to narrow the search?
Choosing the right generic/biosimilar for a Clinical Trial
Discover how to choose the right generic or biosimilar for your clinical trial; we explore key considerations from supply chain reliability to cost savings.